Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)
Clinical trial NCT06931704 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06931704
- Sponsor
- Nantes University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2030-11-30
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.